Results 221 to 230 of about 81,917 (261)

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2021
Shyamala C Navada
exaly  

INHIBITORS OF MEK KINASE

2023
KANOUNI TOUFIKE, KANIA ROBERT S, COX JASON M   +2 more
openaire   +4 more sources

MEK Inhibitor Resistance Mechanisms and Recent Developments in Combination Trials

Cancer Treatment Reviews, 2021
David Gershenson, Eucharist Kun, Kwong K. Wong   +2 more
exaly  

Histone Deacetylase Inhibitors in Medical Therapeutics

Medical Epigenetics, 2021
exaly  

MEK INHIBITORS AND USES THEREOF

2023
CASTRO ALFREDO C, BURKE MICHAEL J, WYNN THOMAS A, RUPPEL SABINE K, SANTILLANA SOTO SERGIO L, HAINES ERIC, XU LAN, ZAVIDIJ OKSANA   +7 more
openaire   +2 more sources

INHIBITORS OF MEK

2008
KOH YUNG-HYO, HONG ZHI, VERNIER JEAN-MICHEL, MADERNA ANDREAS   +3 more
openaire   +4 more sources

A Phase IB Trial of the Oral MEK Inhibitor Trametinib (GSK1120212) in Combination With Everolimus in Patients With Advanced Solid Tumors

Annals of Oncology, 2015
J R Infante, K P Papadopoulos, J C Bendell   +2 more
exaly  

KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS

Cell, 2018
Marzia Capelletti, Haiyun Wang, Sudershan Gondi   +2 more
exaly  

Sarcoidosis Related to Checkpoint and BRAF/MEK Inhibitors in Melanoma

Autoimmunity Reviews, 2020
Joaquim Marcoval, Manuel Rubio-Rivas
exaly  

Titration of Signalling Output: Insights Into Clinical Combinations of MEK and AKT Inhibitors

Annals of Oncology, 2015
Johann de Bono, Udai Banerji, J S de Bono   +2 more
exaly